These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7306889)

  • 41. Tay-Sachs disease in persons of French-Canadian heritage in northern New England.
    Palomaki GE; Williams J; Haddow JE; Natowicz MR
    Am J Med Genet; 1995 May; 56(4):409-12. PubMed ID: 7604851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Voluntary mass screening program for Tay-Sachs disease in Israel].
    Padeh B; Shahar S; Navon R; Modan M; Goldman B
    Harefuah; 1977 Jun; 92(11):481-5. PubMed ID: 885382
    [No Abstract]   [Full Text] [Related]  

  • 43. Issues in medical ethics: 1997. Cases and doubts.
    Zinberg RE
    Mt Sinai J Med; 1998 May; 65(3):210-2. PubMed ID: 9615573
    [No Abstract]   [Full Text] [Related]  

  • 44. Future perspectives for Tay-Sachs disease.
    Desnick RJ; Kaback MM
    Adv Genet; 2001; 44():349-56. PubMed ID: 11596996
    [No Abstract]   [Full Text] [Related]  

  • 45. Late onset Tay-Sachs disease in mice with targeted disruption of the Hexa gene: behavioral changes and pathology of the central nervous system.
    Miklyaeva EI; Dong W; Bureau A; Fattahie R; Xu Y; Su M; Fick GH; Huang JQ; Igdoura S; Hanai N; Gravel RA
    Brain Res; 2004 Mar; 1001(1-2):37-50. PubMed ID: 14972652
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lower frequency of Gaucher disease carriers among Tay-Sachs disease carriers.
    Peleg L; Frisch A; Goldman B; Karpaty M; Narinsky R; Bronstein S; Frydman M
    Eur J Hum Genet; 1998; 6(2):185-6. PubMed ID: 9781065
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tay-Sachs disease: to screen or not to screen.
    Rosner F
    Tradition; 1976; 15(4):101-12. PubMed ID: 11660898
    [No Abstract]   [Full Text] [Related]  

  • 48. Tay-Sachs and abortion legislation.
    Kushner R
    Natl Jew Mon; 1974; 88(11):49-55. PubMed ID: 11663626
    [No Abstract]   [Full Text] [Related]  

  • 49. Economics of screening programs for Tay-Sachs disease.
    Shabat S
    Health Policy; 1999 May; 47(2):183-4. PubMed ID: 10538291
    [No Abstract]   [Full Text] [Related]  

  • 50. The economic returns to community and hospital screening programs for a genetic disease.
    Swint JM; Shapiro JM; Corson VL; Reynolds LW; Thomas GH; Kazazian HH
    Prev Med; 1979 Jul; 8(4):463-70. PubMed ID: 112594
    [No Abstract]   [Full Text] [Related]  

  • 51. Novel mutations, including the second most common in Japan, in the beta-hexosaminidase alpha subunit gene, and a simple screening of Japanese patients with Tay-Sachs disease.
    Tanaka A; Fujimaru M; Choeh K; Isshiki G
    J Hum Genet; 1999; 44(2):91-5. PubMed ID: 10083731
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Tay-Sachs disease: a case report. Interest of ultrastructural studies of cultured skin fibroblasts (author's transl)].
    Charbonne F; Rousseau P; Malpuech G; Geneix A
    Arch Fr Pediatr; 1980 Jan; 37(1):51-3. PubMed ID: 7469686
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Sandhoff's and Tay-Sachs disease--based on our own cases].
    Kokot W; Raczyńska K; Krajka-Lauer J; Iwaszkiewicz-Bilikiewicz B; Wierzba J
    Klin Oczna; 2004; 106(3 Suppl):534-6. PubMed ID: 15636260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Real-time PCR with molecular beacons provides a highly accurate assay for detection of Tay-Sachs alleles in single cells.
    Rice JE; Sanchez JA; Pierce KE; Wangh LJ
    Prenat Diagn; 2002 Dec; 22(12):1130-4. PubMed ID: 12454972
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Usefulness of histograms of erythrocyte size in screening for thalassemic trait].
    Alos T; Mira Y; Vayá A; Aynar J
    Sangre (Barc); 1990 Oct; 35(5):411-2. PubMed ID: 2291153
    [No Abstract]   [Full Text] [Related]  

  • 56. Screening program for Tay-Sachs disease.
    Eisen JD; Baker JS
    Nebr Med J; 1973 May; 58(5):166-7. PubMed ID: 4697954
    [No Abstract]   [Full Text] [Related]  

  • 57. Letter: Screening for Tay-Sachs disease.
    Scriver CR; Gold RJ
    Can Med Assoc J; 1974 Nov; 111(9):899-900. PubMed ID: 4420059
    [No Abstract]   [Full Text] [Related]  

  • 58. Letter: Possible hazards in screening of adolescents for Tay-Sachs disease.
    Stone MH
    N Engl J Med; 1976 Jul; 295(2):113. PubMed ID: 1272314
    [No Abstract]   [Full Text] [Related]  

  • 59. Tay-Sachs screening clinic.
    Gitelman BJ; Sears EV; Partington MW
    Can Med Assoc J; 1981 Oct; 125(8):814, 816. PubMed ID: 7306889
    [No Abstract]   [Full Text] [Related]  

  • 60. Tay-Sachs disease prevention in Minnesota. Role of physician advocacy in carrier screening.
    Lipsitz DJ; Anderson VE; O'Brien JF; Desnick RJ
    Minn Med; 1986 May; 69(5):272-5. PubMed ID: 3736533
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.